派替化学药物的II期临床试验。欧洲癌症治疗研究组织（E.O.R.T.C）临床筛查协作组。 - Suppr | 超能文献

A phase II clinical trial of peptichemio. Clinical screening cooperative group of European Organisation on Research on Treatment of Cancer (E.O.R.T.C).

出版信息

Biomedicine. 1977 Nov;27(8):290-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

A phase II clinical trial of peptichemio. Clinical screening cooperative group of European Organisation on Research on Treatment of Cancer (E.O.R.T.C).派替化学药物的II期临床试验。欧洲癌症治疗研究组织（E.O.R.T.C）临床筛查协作组。

Biomedicine. 1977 Nov;27(8):290-4.

2

Clinical trial of peptichemio in solid tumors of childhood.小儿实体瘤中派普替米奥的临床试验。

Cancer Treat Rep. 1978 Jul;62(7):1015-9.

3

Peptichemio in children with neoplastic disease.肿瘤性疾病患儿的派普西米奥疗法

An Esp Pediatr. 1976 Dec;9(9):76-83.

4

Preliminary trials in the treatment of female gynaecological tumours by Peptichemio.胃酶抑素治疗女性妇科肿瘤的初步试验。

Panminerva Med. 1976 May-Jun;18(5-6):170-4.

5

[Recent clinical experiences in the treatment of solid tumors with Peptichemio alone or in combination].[单独或联合使用派普西咪治疗实体瘤的近期临床经验]

G Ital Chemioter. 1974 Jan-Jun;21(1):33-5.

6

[Efficacy of peptichemio in neuroblastoma].[派普化学疗法在神经母细胞瘤中的疗效]

Minerva Pediatr. 1978 May 15;30(9):741-51.

7

[Results of 18 months of chemotherapeutic treatment with Peptichemio].[使用派普化疗药进行18个月化疗治疗的结果]

G Ital Chemioter. 1974 Jan-Jun;21(1):28-32.

8

[Results in 67 patients with malignant tumors treated by Peptichemio].[67例恶性肿瘤患者接受派普化疗的治疗结果]

G Ital Chemioter. 1974 Jan-Jun;21(1):18-21.

9

[Clinical evaluation of Peptichemio in some hemoblastoses and solid tumors].[Peptichemio在某些血液病和实体瘤中的临床评估]

G Ital Chemioter. 1974 Jan-Jun;21(1):22-7.

10

[Use of a multipeptide anti-tumor complex in the treatment of primary and secondary neoplastic serositis].[一种多肽抗肿瘤复合物在原发性和继发性肿瘤性浆膜炎治疗中的应用]

G Ital Chemioter. 1974 Jan-Jun;21(1):13-7.

引用本文的文献

1

Peptichemio induction therapy in myelomatosis.

Cancer Chemother Pharmacol. 1982;8(1):9-16. doi: 10.1007/BF00292864.

2

Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity.

Cancer Chemother Pharmacol. 1984;12(2):70-6. doi: 10.1007/BF00254592.

3

New cancer chemotherapy drugs in Europe.

Cancer Chemother Pharmacol. 1978;1(1):5-13. doi: 10.1007/BF00253141.

4

Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.长春地辛用于白血病和血液肉瘤患者诱导缓解的II期试验。

Cancer Chemother Pharmacol. 1979;2(4):247-55. doi: 10.1007/BF00257189.